About this trial
The goal of this clinical trail is to determine if bilateral erector spinae plane block alone can provide good perioperative analgesia for abdominoplastic surgery patients or it is better to give combined bilateral rectus sheath and erector spinae plane blocks to achieve effective intraoperative and postoperative analgesia with minimal morphine consumption in such operations in which there is an extensive surgical dissection and a high risk of respiratory problems.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients Age from 21 to 60 years ,Male and female patients ,ASA I, II patients scheduled for elective abdominoplastic surgeries during the study duration.
Disqualifiers
Patient refusal, Age less than 21 and above 60 years old, ASA III, IV patients., Infection at the site of injection, Opioid addiction, Allergy to any used substances (lidocaine, bupivacaine)., Preexisting severe or uncontrolled respiratory, renal or cardiac disease. , INR more than 1.5 and platelets less than 100000.
Trial design
Crossover
Treatments tested in this trial
Erector spinae plane block
Procedure/Surgerythe patient will recieve ultrasound guided erector spinae plane blockbe. A 20-gauge needle will be placed between the erector spinae muscle and the thoracic transverse processes at the level of T10 using an 'in plane' technique, 20 ml of (0.25% bupivacaine and 1% xylocaine) will be injected on each side.
Rectus sheath block
Procedure/Surgerythe patient will recieve ultrasound guided rectus sheath block. An 18-gauge needle will be introduced- in plane- just below the costal margin at an angle of approximately 45 degrees to the skin between the rectus abdominis muscle and posterior rectus sheath. 10 ml of (0.25% bupivacaine and 1% xylocaine) will be injected on each side.
Treatment groups
Trial outcomes
Primary outcomes
Primary outcome
Visual Analogue Scale (VAS) measures pain intenesity one hour after extubation
Secondary outcomes
Secondary Outcome
Total morphine consumption during 1st 24 hours postoperatively
Secondary Outcome
Total intraoperative fentanyl consumption.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.